LOAMU
VNDA icon

Lombard Odier Asset Management (USA)’s Vanda Pharmaceuticals VNDA Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-395,000
Closed -$6.57M – 242
2016
Q3 		$6.57M Buy
+395,000
New +$5.32M 0.61% 52
2014
Q2 		– Sell
-150,000
Closed -$2.44M – 228
2014
Q1 		$2.44M Hold
150,000
– – 0.09% 152
2013
Q4 		$1.86M Buy
+150,000
New +$1.51M 0.08% 132

Other funds holding VNDA

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s VNDA Position: Q4 2016 in Review

Lombard Odier Asset Management (USA) sold out of Vanda Pharmaceuticals (VNDA) in Q4 2016, closing a stake of 395,000 shares — an estimated $6.57M sold.

Lombard Odier Asset Management (USA) first reported a position in VNDA in Q4 2013 and held it in 3 quarters. The position peaked at $6.57M in Q3 2016. 141 funds tracked by Wall St. Rank hold VNDA as of Q4 2016.

  • Lombard Odier Asset Management (USA) reported no remaining Vanda Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 395,000 Vanda Pharmaceuticals shares in Q4 2016, an estimated $6.57M.
  • Lombard Odier Asset Management (USA) first reported a position in Vanda Pharmaceuticals in Q4 2013 and held it in 3 quarters.
  • Lombard Odier Asset Management (USA)'s Vanda Pharmaceuticals position peaked at $6.57M in Q3 2016.
  • 141 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2016.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2016, filed 15 Feb 2017.